Changhoon Yoo
0000-0002-1451-8455
Publication & Citation Trends
Publications
453 total
Proteogenomic profiling predicts outcomes of adjuvant chemotherapy in extrahepatic cholangiocarcinoma.
Cited by 1
Semantic Scholar
A Phase II Trial of Pemetrexed Plus Oxaliplatin in Patients With Advanced Biliary Tract Cancer After Failure of Gemcitabine Plus Cisplatin-based Chemotherapy
Cited by 0
Semantic Scholar
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study PDF
Cited by 273
OpenAlex
Disease Etiology Impact on Outcomes of Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab: A Real-World, Multicenter Study OA
Cited by 17
Semantic Scholar
Impact of body mass index on the prognosis of unresectable HCC patients receiving first‐line Lenvatinib or atezolizumab plus bevacizumab
Cited by 4
Semantic Scholar
Abstract 6422: Comprehensive proteogenomic profiling and biomarker analyses in resected extrahepatic cholangiocarcinoma: A prespecified exploratory analysis of the phase 2 STAMP trial
Cited by 0
Semantic Scholar
CX-4945 (Silmitasertib) Induces Cell Death by Impairing Lysosomal Utilization in KRAS Mutant Cholangiocarcinoma Cell Lines
Cited by 4
Semantic Scholar
Abstract 4325: CX-4945 (Silmitasertib) induces cell death through impairment of lysosomal utilization in KRAS mutant cholangiocarcinoma cell lines
Cited by 0
Semantic Scholar
Research Topics
Cholangiocarcinoma and Gallbladder Cancer Studies
(135)
Pancreatic and Hepatic Oncology Research
(120)
Hepatocellular Carcinoma Treatment and Prognosis
(83)
Cancer Genomics and Diagnostics
(65)
Gastric Cancer Management and Outcomes
(57)
Affiliations
Ulsan College
University of Connecticut
Korea Advanced Institute of Science and Technology
Second Military Medical University
Peking University